{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:44Z","timestamp":1707525164697},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,9]]},"DOI":"10.7759\/cureus.43218","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:29:03Z","timestamp":1691598543000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Responsive to Intravenous Immunoglobulin (IVIG) Therapy in a Pediatric Patient"],"prefix":"10.7759","author":[{"given":"Rochita","family":"Kadam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Fathalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed A","family":"Hosain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Al BinAli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000607","article-title":"Update on pediatric optic neuritis","volume":"30","author":"Lock JH","year":"2019","unstructured":"Lock JH, Newman NJ, Biousse V, Peragallo JH. Update on pediatric optic neuritis. Curr Opin Ophthalmol. 2019, 30:418-25. 10.1097\/ICU.0000000000000607","journal-title":"Curr Opin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1335-x","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","volume":"15","author":"Lee HJ","year":"2018","unstructured":"Lee HJ, Kim B, Waters P, et al.. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation. 2018, 15:302. 10.1186\/s12974-018-1335-x","journal-title":"J Neuroinflammation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens AL","year":"2020","unstructured":"Bruijstens AL, Wendel EM, Lechner C, et al.. E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020, 29:41-53. 10.1016\/j.ejpn.2020.10.005","journal-title":"Eur J Paediatr Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101917","article-title":"Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients","volume":"39","author":"Giacomini T","year":"2020","unstructured":"Giacomini T, Foiadelli T, Annovazzi P, et al.. Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients. Mult Scler Relat Disord. 2020, 39:101917. 10.1016\/j.msard.2019.101917","journal-title":"Mult Scler Relat Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200035","article-title":"Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome","volume":"9","author":"Wendel EM","year":"2022","unstructured":"Wendel EM, Thonke HS, Bertolini A, et al.. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome. Neurol Neuroimmunol Neuroinflamm. 2022, 9:10.1212\/NXI.0000000000200035","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol CL","year":"2020","unstructured":"de Mol CL, Wong Y, van Pelt ED, et al.. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020, 26:806-14. 10.1177\/1352458519845112","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009758","article-title":"Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder","volume":"95","author":"Chen JJ","year":"2020","unstructured":"Chen JJ, Flanagan EP, Bhatti MT, et al.. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020, 95:e111-20. 10.1212\/WNL.0000000000009758","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152680-a-case-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-optic-neuritis-responsive-to-intravenous-immunoglobulin-ivig-therapy-in-a-pediatric-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:39Z","timestamp":1707508899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152680-a-case-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-optic-neuritis-responsive-to-intravenous-immunoglobulin-ivig-therapy-in-a-pediatric-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.43218","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}